Clinical Trials
36 trialsINSPIRE
Singlera Genomics Inc.
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
VUBAR
Universitair Ziekenhuis Brussel
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
FAPI
Guangdong Provincial People's Hospital
UPLIFT
Massachusetts General Hospital
Patient-Derived Xenografts to Reduce Cancer Health Disparities
University of California, Davis
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
ICEMELT
Western Sydney Local Health District
Anxiety Before Non-cardiac Surgery in Adults
RenJi Hospital
CADENCE
MiRXES Pte Ltd
REGOMUNE
Institut Bergonié
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
PASSION
Assistance Publique - Hôpitaux de Paris
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients
RenJi Hospital
Safety and Feasibility of Reversible Induction Strategy
RenJi Hospital
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
PIONEER
SpeciCare
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
MultiVir, Inc.
Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid Biopsy
The First Affiliated Hospital with Nanjing Medical University
Study to Evaluate the Safety of Nanoxel M Inj.
Samyang Biopharmaceuticals Corporation
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Shenzhen BinDeBio Ltd.
Laser Fluorescence in Cancer Surgical Treatment
Instituto do Cancer do Estado de São Paulo
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
CytoMed Therapeutics Pte Ltd
Study of EOC317 in Chinese Patients With Advanced Solid Tumors
Taizhou EOC Pharma Co., Ltd.
Prospective Analysis of Robot-Assisted Surgery
Instituto do Cancer do Estado de São Paulo
Circulating Tumor DNA Exposure in Peripheral Blood
Quantgene Inc.
A Study Evaluating MM-310 in Patients With Solid Tumors
Merrimack Pharmaceuticals
The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study
Università degli Studi 'G. d'Annunzio' Chieti e Pescara
CARTEPC
First Affiliated Hospital of Chengdu Medical College
Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors
National University Hospital, Singapore
SU006668 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel
Meir Medical Center